Close Menu

NEW YORK — CND Life Sciences said on Monday that it has been awarded a $2.4 million grant from the National Institutes of Health to support the clinical development of its Syn-One neurodegenerative disease test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.